Vivani Medical
VANI
38 hedge funds and large institutions have $6.47M invested in Vivani Medical in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 12 closing their positions.
3,000% more call options, than puts
Call options by funds: $31K | Put options by funds: $1K
15% more capital invested
Capital invested by funds: $5.61M → $6.47M (+$860K)
0.58% less ownership
Funds ownership: 6.63% → 6.05% (-0.58%)
12% less funds holding
Funds holding: 43 → 38 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$287K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$121K |
| 3 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$74.5K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$73.6K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$24.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$347K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
-$100K |
| 3 |
EW
Evoke Wealth
Los Angeles,
California
|
-$99.9K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$98.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$82.4K |
VANI Hedge Fund Activity: Q2 2026 in Review
38 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2026, worth a combined $6.47M — up 15% from $5.61M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of VANI and 7 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Capital Management, adding an estimated $287K. The largest seller was UBS Group, cutting an estimated $347K.
- 38 institutional investors held Vivani Medical (VANI) as of Q2 2026, down from 43 in Q1 2026.
- Funds reported $6.47M of Vivani Medical stock for Q2 2026, up 15% quarter-over-quarter.
- 7 funds opened new Vivani Medical positions in Q2 2026 and 12 closed out, a net change of -5 holders.
- The largest Vivani Medical buyer in Q2 2026 was Vanguard Capital Management, an estimated $287K added.
- The largest Vivani Medical seller in Q2 2026 was UBS Group, an estimated $347K sold.
Based on aggregated 13F filings for Q2 2026.